About Element Science
Element Science is an innovative San Francisco-based medical device and digital health company focused on developing solutions at the intersection of clinical-grade wearable devices, machine learning algorithms and lifesaving therapies to address the needs of high-risk cardiovascular patients, primarily as they transition from the hospital to home.
The company was founded in 2011 by Uday Kumar, MD, a cardiac electrophysiologist by training, and founder of iRhythm Technologies (NASD: IRTC), a leading digital healthcare company focused on cardiac rhythm diagnosis.
Element Science is developing a proprietary next-generation wearable digital platform that unites patient-centric human factor engineering, sophisticated machine learning algorithm development principles, and rigorous electromechanical medical device development standards. The platform will address leading causes of death and hospitalization due to heart disease.
Our Focus
Developing solutions that address leading causes of death and hospitalization due to heart disease.
Our Approach
User-centric design approach that focuses on the life of a patient.
Rigorous approach to medical device development.
Integration and application of data science and machine learning.
By putting the patient first, the team at Element Science seeks to redefine what lifesaving medical devices can be.
Our Team
We have assembled an exceptional team with expertise in wearable patches, consumer-oriented design, and machine learning algorithms.
Leadership
Staff
Element Science is funded by:
Third Rock Ventures, Google Ventures, Deerfield Healthcare, Qiming Ventures Partners USA, Cormorant Asset Management, and Invus Opportunities.
On March 3, 2020, Element Science announced a $145.6 million Series C financing round to fund the completion of clinical studies and initial commercialization of its Sudden Cardiac Death (SCD) wearable defibrillator as well as the development of a family of products built upon its proprietary platform to address related unmet clinical needs.
Press and Media:
5/23/2023
Element Science Announces Completion of Enrollment in the Jewel IDE Study Evaluating the Jewel Patch Wearable Cardioveter Defibrillator (P-WCD)
5/21/2023
Heart Rhythm, Vol 20, No 5S, May 2023, Successful Defibrillation Of Ventricular Fibrillation With A Novel Patch Wearable Cardioverter Defibrillator
5/9/2023
Element Science Adds Kathy Jeffery as Chief People Officer
10/26/22
Element Science Appoints Trish Howell as Chief Operating Officer
8/2/22
Element Science Announces First Patient Save With Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)